Drug details
Roctavian (valoctocogene roxaparvovec-rvox suspension)
type of Clotting Factors, Gene Therapy
Roctavian (valoctocogene roxaparvovec-rvox) is an adeno-associated virus vector-based gene therapy indicated for the treatment of adults with severe hemophilia A (congenital factor VIII deficiency with factor VIII activity less than 1 IU/dL) without pre-existing antibodies to adeno-associated virus serotype 5 detected by an FDA-approved test.
This drug may have the following side effects:
- nausea,
- rash,
- vomiting,
- diarrhea,
- headache,
- fatigue,
- abdominal pain,
- dizziness, and
The following drugs are related to Roctavian, either as a replacement or used together:
- Advate ([antihemophilic factor (recombinant), plasma/albumin-free method] for intravenous injection)
- Adynovate (antihemophilic factor (recombinant), pegylated for injection)
- Afstyla (antihemophilic factor recombinant intravenous injection)
- Alphanate (antihemophilic factor)
- Amicar (aminocaproic acid)
- Feiba VH (anti-inhibitor coagulant complex, vapor heated)
- Xyntha (antihemophilic factor)
- Kogenate FS (antihemophilic factor (recombinant))
- Novoeight (antihemophilic factor (recombinant) lyophilized powder for intravenous injection)
- Eloctate (antihemophilic factor (recombinant), fc fusion protein for intravenous infusion)
- Jivi (antihemophilic factor (recombinant), pegylated-aucl for injection)
- Nuwiq (antihemophilic factor recombinant intravenous infusion)
- Cyklokapron (tranexamic acid)
- DDAVP (desmopressin acetate tablets)
- DDAVP Injection (desmopressin acetate injection)
- DDAVP Nasal Spray (desmopressin acetate nasal spray)
- DDAVP Rhinal Tube (desmopressin acetate rhinal tube)
- Stimate (desmopressin acetate nasal spray)
- Hemlibra (emicizumab-kxwh injection, for subcutaneous use)
- Esperoct ([antihemophilic factor (recombinant), glycopegylated-exei] injection)
- Hemofil-M ([antihemophilic factor (human), method m, monoclonal purified] nanofiltered)